E-LIB Suche - Ergebnisse für: Short, Nicholas

1

Efficacy of Chemotherapy-Free Regimens in the Treatment of ..:

Ali, Muhammad Ashar ; Aiman, Wajeeha ; Kantarjian, Hagop...
Clinical Lymphoma Myeloma and Leukemia. , 2024

Link: https://doi.org/10.1016/..

2

Phase 1 study of azacitidine in combination with quizartini..:

Montalban-Bravo, Guillermo ; Jabbour, Elias ; Chien, Kelly...
Leukemia Research. 142 (2024) - p. 107518 , 2024

Link: https://doi.org/10.1016/..

3

Prognostic risk signature in patients with acute myeloid le..:

Bataller, Alex ; Bazinet, Alexandre ; DiNardo, Courtney D....
Blood Advances. 8 (2024) 4 - p. 927-935 , 2024

Link: https://doi.org/10.1182/..

4

NPM1‐mutated myeloid neoplasms are a unique entity not defi..:

Gener‐Ricos, Georgina ; Bataller, Alex ; Rodriguez‐Sevilla, Juan Jose...
Cancer. , 2024

Link: https://doi.org/10.1002/..

5

Reduced dose azacitidine plus venetoclax as maintenance the..:

Bazinet, Alexandre ; Kantarjian, Hagop ; Bataller, Alex...
The Lancet Haematology. 11 (2024) 4 - p. e287-e298 , 2024

Link: https://doi.org/10.1016/..

6

Outcome of Patients With Relapsed Acute Promyelocytic Leuke..:

Sasaki, Koji ; Ravandi, Farhad ; Kadia, Tapan...
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 6 - p. 375-381 , 2024

Link: https://doi.org/10.1016/..

7

Exploring the landscape of somatic ASXL2 mutations in myelo..:

Abuasab, Tareq ; Borthakur, Gautam ; Kanagal‐Shamanna, Rashmi...
American Journal of Hematology. 99 (2024) 7 - p. 1434-1436 , 2024

Link: https://doi.org/10.1002/..

8

Results of ponatinib as frontline therapy for chronic myelo..:

Haddad, Fadi G. ; Sasaki, Koji ; Nasr, Lewis...
Cancer. , 2024

Link: https://doi.org/10.1002/..

9

Lower intensity therapy with cladribine/low dose cytarabine..:

Senapati, Jayastu ; Kantarjian, Hagop M. ; Bazinet, Alexandre...
Cancer. , 2024

Link: https://doi.org/10.1002/..

10

SOHO State of the Art Updates and Next Questions, Measurabl..:

Short, Nicholas J. ; Jabbour, Elias ; Kantarjian, Hagop
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 7 - p. 427-432 , 2024

Link: https://doi.org/10.1016/..

11

Azacitidine Post-transplant Maintenance Improves Disease Pr..:

Pasvolsky, Oren ; Saliba, Rima M. ; Popat, Uday R....
Clinical Lymphoma Myeloma and Leukemia. , 2024

Link: https://doi.org/10.1016/..

12

Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinat..:

Short, Nicholas J. ; Jabbour, Elias ; Jamison, Trevor...
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 4 - p. e168-e173 , 2024

Link: https://doi.org/10.1016/..

13

SOHO State of the Art Updates and Next Questions | Next Que..:

Senapati, Jayastu ; Kantarjian, Hagop ; Haddad, Fadi G....
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 6 - p. 333-339 , 2024

Link: https://doi.org/10.1016/..

14

Combination therapy with novel agents for acute myeloid leu..:

Jen, Wei‐Ying ; Kantarjian, Hagop ; Kadia, Tapan M....
British Journal of Haematology. , 2024

Link: https://doi.org/10.1111/..

15

Targetable genetic abnormalities in patients with acute mye..:

Bataller, Alex ; DiNardo, Courtney D. ; Bazinet, Alexandre...
American Journal of Hematology. 99 (2024) 4 - p. 792-796 , 2024

Link: https://doi.org/10.1002/..